Grand Rapids, MI — Grand Rapids, Michigan

Grand Rapids, MI is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Grand Rapids, MI has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration.

Sponsors: Ollin Biosciences, Inc., EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Grand Rapids, MI?

Grand Rapids, MI has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Grand Rapids, MI conducted?

Grand Rapids, MI has 2 clinical trials on record, with 1 currently active. Their work covers Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration.

Is Grand Rapids, MI accredited by Crixeo Health?

Grand Rapids, MI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Grand Rapids, MI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.